Peripheral Neuropathy Trial, Recruiting NCT07349173 Sponsor: Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est Condition: Peripheral Neuropathy
Back to Peripheral Neuropathy

Peripheral Neuropathy Trial, Recruiting

NCT07349173
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

For patients:

  • Adults aged 18 or older
  • People who have been avoiding using one arm, hand, or part of their hand in daily life for more than 3 months
  • People who have no medical reason preventing them from doing tasks that require physical effort in daily life
  • People with finger avoidance issues who show at least 2 signs of this on a specific hand assessment called the "Bilan 400 points" (tests 3 and 4) (confirm with trial site)
  • People who are enrolled in a French social security scheme (confirm with trial site)
  • People who are able to follow and understand simple instructions

For healthy comparison participants (controls):

  • Adults aged 18 or older
  • People who have no history of arm or hand problems that left lasting effects

Who may not be able to join:

  • People with vision problems
  • People with a brain or nervous system condition (such as stroke or multiple sclerosis)
  • People with a psychiatric condition that is not currently stable
  • People who have difficulty communicating or understanding information
  • People who are under legal guardianship or who are unable to give informed consent
  • Women who are pregnant or breastfeeding
  • People with a neck condition that would make wearing a virtual reality headset unsafe
  • People who have epilepsy
  • People with an arm or hand condition that is unrelated to the avoidance issue being studied
  • People who are unable to stand for 40 minutes

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33 3 83 52 98 80

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
Registry
ClinicalTrials.gov
Start date
4 December 2025
Est. completion
1 July 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Judgment Error of Reachability

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov